While only slightly past the midway point of 2023, it has already been a busy year for developments in drug pricing. Notably, CMS released its final guidance in preparation for price.
In conjunction with the surge in state legislative efforts to regulate the pharmacy benefit manager (PBM) industry, Congress and federal agencies have ramped up PBM oversight efforts as part of the ongoing.
Pharmacy Benefit Manager Reform Act requires PBM entities to operate with increased transparency and limit certain avenues by which PBMs may retain profits.PBM Transparency Act would make it illegal for PBMs to engage in spread pricing, claw back any portion of reimbursement
In conjunction with the surge in state legislative efforts to regulate the pharmacy benefit manager (PBM) industry, Congress and federal agencies have ramped up PBM oversight efforts as.